Interim results are in from a study evaluating whether adding selumetinib to RAI improves complete response, irrespective of MAPK pathway alterations.
A study looks at how dietary patterns impact colorectal cancer outcomes before and after diagnosis.
We spoke with Erin McMenamin, CRNP, of Penn Medicine, about the recent study on opioid switching in cancer patients.
A study takes a closer look at colorectal cancer screening incentives among New York State Medicaid managed care patients.
The recommendations on Trial Reporting in Immuno-Oncology aim to enchance understanding of efficacy and toxicity outcomes in immuno-oncology trials.
Many lung cancer patients may be unaware of the potential benefits of exercise.
We spoke with Kelly Hogan, MS, RD, about the recent JAMA study on the association between organic food consumption and cancer risk.
Cancer patients in England will receive a new game-changing therapy treatment under the first negotiated deal of its kind struck in Europe.
An inflammation marker was associated with several unfavorable characteristics in diffuse large B-cell lymphoma.
The frequency of hepatotoxic immune-related adverse events varied in patients receiving one vs multiple chemotherapy agents.